We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
-9.48%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$116B
AUM Growth
-$22.1B
(-16%)
Cap. Flow
+$6B
Cap. Flow
% of AUM
5.18%
Top 10 Holdings %
Top 10 Hldgs %
17.41%
Holding
4,413
New
281
Increased
1,595
Reduced
1,871
Closed
461
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares China Large-Cap ETF
FXI
|
+$473M |
| 2 |
AGN
Allergan plc
AGN
|
+$384M |
| 3 |
Linde
LIN
|
+$332M |
| 4 |
McKesson
MCK
|
+$329M |
| 5 |
Broadcom
AVGO
|
+$300M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 2 |
AT&T
T
|
+$525M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$373M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$285M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$269M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.9% |
| 2 | Healthcare | 12.82% |
| 3 | Financials | 9.51% |
| 4 | Consumer Discretionary | 7.09% |
| 5 | Communication Services | 6.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
CorVel
CRVL
$3.19B
| $408K | ﹤0.01% |
22,443
+4,194
| +23% | +$109K |
|
|
ABTX
3127
DELISTED
Allegiance Bancshares
ABTX
| $408K | ﹤0.01% |
16,948
+2,394
| +16% | +$80.5K |
|
3128
PC Connection
CNXN
$2.12B
| $407K | ﹤0.01% |
9,865
-9,201
| -48% | -$408K |
|
3129
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.4B
| $406K | ﹤0.01% |
11,024
-84,985
| -89% | -$4.22M |
|
3130
CALL
Southwest Airlines
LUV
$23B
| $406K | ﹤0.01% |
11,400
-31,200
| -73% | -$1.55M |
|
3131
SiriusPoint
SPNT
$2.68B
| $406K | ﹤0.01% |
54,770
-143,944
| -72% | -$1.38M |
|
3132
Cactus
WHD
$5.44B
| $406K | ﹤0.01% |
34,992
+1,441
| +4% | +$36.2K |
|
|
OSG
3133
Octave Specialty Group
OSG
$222M
| $405K | ﹤0.01% |
32,749
-13,875
| -30% | -$266K |
|
3134
Atara Biotherapeutics
ATRA
$76.1M
| $405K | ﹤0.01% |
1,904
-438
| -19% | -$139K |
|
|
XOMA
3135
DELISTED
Xoma
XOMA
| $405K | ﹤0.01% |
19,938
-34,000
| -63% | -$785K |
|
3136
Gossamer Bio
GOSS
$87M
| $404K | ﹤0.01% |
39,866
-8,139
| -17% | -$106K |
|
3137
Lantheus
LNTH
$6.59B
| $404K | ﹤0.01% |
31,644
+6,182
| +24% | +$98.8K |
|
3138
United Parks & Resorts
PRKS
$2.12B
| $404K | ﹤0.01% |
36,691
-4,146
| -10% | -$113K |
|
|
PFC
3139
DELISTED
Premier Financial Corp. Common Stock
PFC
| $404K | ﹤0.01% |
27,445
+9,689
| +55% | +$247K |
|
|
BMTC
3140
DELISTED
Bryn Mawr Bank Corp
BMTC
| $404K | ﹤0.01% |
14,205
+1,847
| +15% | +$64.8K |
|
3141
Orthofix Medical
OFIX
$419M
| $403K | ﹤0.01% |
14,386
-3,178
| -18% | -$123K |
|
3142
Assembly Biosciences
ASMB
$529M
| $402K | ﹤0.01% |
2,263
+959
| +74% | +$206K |
|
3143
Brookdale Senior Living
BKD
$3.4B
| $402K | ﹤0.01% |
128,779
-14,738
| -10% | -$85.9K |
|
3144
CALL
PNC Financial Services
PNC
$101B
| $402K | ﹤0.01% |
+4,200
| New | +$564K |
|
3145
REX American Resources
REX
$1.41B
| $402K | ﹤0.01% |
51,912
-2,604
| -5% | -$29.6K |
|
|
MRO
3146
PUT
DELISTED
Marathon Oil Corporation
MRO
| $402K | ﹤0.01% |
122,300
-512,700
| -81% | -$4.73M |
|
3147
Core Laboratories
CLB
$521M
| $401K | ﹤0.01% |
38,835
-14,052
| -27% | -$393K |
|
|
TRTX
3148
TPG RE Finance Trust
TRTX
$618M
| $401K | ﹤0.01% |
73,081
-143,378
| -66% | -$2.48M |
|
3149
AngioDynamics
ANGO
$649M
| $400K | ﹤0.01% |
38,266
-5,668
| -13% | -$71.2K |
|
|
GB
3150
DELISTED
Global Blue Group Holding
GB
| $399K | ﹤0.01% |
39,408
+14,408
| +58% | +$151K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q1 2020 Portfolio in Review
As of Q1 2020, Credit Suisse held 4,413 positions worth $116B, down 16% from $138B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse deployed $6B of net new capital in Q1 2020, opening 281 new positions and adding to 1,595 existing holdings. Its largest new stake was iShares US Healthcare Providers ETF: 4,155,000 shares worth $139M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $995M trimmed.
- Credit Suisse's largest Q1 2020 buy was iShares US Healthcare Providers ETF: 4,155,000 shares worth $139M.
- Credit Suisse added most to iShares China Large-Cap ETF in Q1 2020, an estimated $473M increase.
- Credit Suisse's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $995M.
- Credit Suisse fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $285M.
- Credit Suisse's ten largest holdings make up 17% of its $116B portfolio in Q1 2020.
- Credit Suisse opened 281 new positions and closed 461 in Q1 2020.
- Credit Suisse's portfolio value fell 16% quarter-over-quarter to $116B.
Based on Credit Suisse's 13F filing for Q1 2020, filed 13 May 2020.